Stanford Health Care celebrated a major milestone today in the construction of the new Stanford Hospital with the ceremonial ‘Topping Off’ of the steel structure. Construction work
View the original here:
Stanford Health Care Holds ‘Topping Off’ Ceremony for New Hospital Building in Palo Alto
The Bill & Melinda Gates Foundation said on Friday it had awarded Stanford University a $50 million grant to accelerate vaccine development efforts for the world's most deadly diseases, including AIDS and malaria. The $50 million grant over 10 years will go toward establishing the Stanford Human Systems Immunology Center on the school's California campus, the foundation and university said in a …
Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve …
THOUSAND OAKS, Calif., SOUTH PASADENA, Calif. and PALO ALTO, Calif., Jan. 29, 2015 /PRNewswire/ — Amgen (AMGN), The Familial Hypercholesterolemia Foundation and Stanford Medicine today announced the launch of the FIND (FLAG, IDENTIFY, NETWORK, DELIVER) FH™ initiative. With financial support from Amgen, the FIND FH initiative is a large-scale program to identify and engage individuals and …
( Stanford University Medical Center ) A new procedure can quickly and efficiently increase the length of human telomeres, the protective caps on the ends of chromosomes that are linked to aging and disease, according to scientists at the Stanford University School of Medicine.
View original post here:
Telomere extension turns back aging clock in cultured human cells, Stanford study finds
Induced pluripotent stem cells made from patients with a form of blistering skin disease can be genetically corrected and used to grow back healthy skin cells in laboratory dishes, researchers at the Stanford University School of Medicine have found. They've termed the new technique 'therapeutic reprogramming.'
Biotech Science News Unveils the Top Life Science Organizations Dominating Stem Cell Research, Cancer/Cell Biology …
Harvard, University of California, NIH, MD Anderson and Stanford dominate the list.
As many as one-third of previously published randomized clinical trials could be re-analyzed in ways that modify the conclusions of how many or what types of patients need to be treated, according to a new study by researchers at the Stanford University School of Medicine.
See original article:
Re-analysis of clinical trial data can change conclusions, say Stanford researchers